AnalystsNeil ChatterjiNeil Chatterji's Stock Forecasts
AnalystsNeil Chatterji
Analyst Ranking
Bottom 10%
#4521 out of 4986 analysts
Average Return
-7.64%
Win Rate
20%4 out of 20
Risk vs Reward
Poor
Good
Neil Chatterji's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Optimizerx CorpOPRX | +219.84% | $4.94 | $15.80 | 2024-12-24 - 2025-08-19 | Strong Buy |
Establishment Labs Holdings IncESTA | +103.03% | $22.78 | $46.25 | 2023-11-09 - 2024-11-08 | Strong Buy |
Hyperfine IncHYPR | +85.44% | $1.03 | $1.91 | 2022-10-04 - 2023-10-03 | Strong Buy |
Stereotaxis IncSTXS | +4.74% | $2.32 | $2.43 | 2023-03-06 - 2024-03-05 | Strong Buy |
Neil Chatterji Analyst Color
Get additional color on Neil Chatterji's coverage of popular stocks
Neil Chatterji's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Clearpoint Neuro IncCLPT | 4 | Strong Buy | $28.00 | +167.69% | Maintains | 4 months ago |
Optimizerx CorpOPRX | 3 | Strong Buy | $13.00 | -17.72% | Maintains | 8 months ago |
AUGX | 3 | Strong Buy | $5.50 | N/A | Reinstates | a year ago |
Establishment Labs Holdings IncESTA | 2 | Strong Buy | $50.00 | N/A | Maintains | 2 years ago |
Silk Road Medical IncSILK | 3 | Hold | $14.00 | N/A | Downgrades | 2 years ago |
Accuray IncARAY | 1 | Strong Buy | $7.50 | N/A | Reiterates | 2 years ago |
Zumiez IncZUMZ | 2 | Hold | $18.00 | N/A | Maintains | 2 years ago |
Koru Medical Systems IncKRMD | 1 | Strong Buy | $4.50 | N/A | Initiates Coverage On | 2 years ago |
Hyperfine IncHYPR | 3 | Strong Buy | $3.50 | N/A | Maintains | 2 years ago |
Stereotaxis IncSTXS | 2 | Strong Buy | $5.50 | N/A | Maintains | 2 years ago |
Paragon 28 IncFNA | 1 | Strong Buy | $32.00 | N/A | Initiates Coverage On | 3 years ago |
Butterfly Network IncBFLY | 1 | Strong Buy | $9.50 | N/A | Initiates Coverage On | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.